Does bpc157 reduce hypertrophy?
Sources:
No—BPC-157 is not described as reducing hypertrophy. It is discussed mainly as a tissue-repair peptide, though its anti-inflammatory action could matter when inflammation is part of the exercise response.
- Tissue repair: BPC-157 is associated with injury-site angiogenesis and fibroblast migration, processes described in connection with healing and repair—not hypertrophy reduction.
- Growth hormone receptors: BPC-157 may upregulate growth hormone receptors; the discussion describes this as potentially making growth hormone signaling more effective, not as suppressing muscle growth.
- Human evidence: The evidence is described as predominantly animal research, with very limited human clinical data and substantial reliance on anecdotes.
- Tumor-growth concern: Increased blood supply and growth-factor signaling could potentially support tumor growth, so tumor risk is raised as a caution.
Answers are generated by AI and can contain mistakes.
Related questions

Take notes while listening to Huberman Lab

